HSIL lesion of the cervix uteri, vagina or vulva

N14_FEMALE_GENITAL_HSIL

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D06, D07.1&, D07.2&, N87.1, N87.2, N89.1, N89.2, N90.1, N90.2 Hospital discharge: ICD-9 — 6221B\|6221C\|2331A\|2333A\|6230B\|6230C\|2333B Cause of death: ICD-10 — D06, D07.1&, D07.2&, N87.1, N87.2, N89.1, N89.2, N90.1, N90.2 Cause of death: ICD-9 — 6221B\|6221C\|2331A\|2333A\|6230B\|6230C\|2333B 2 out of 7 registries used, show all original rules.	8982
4. Check minimum number of events None	8982
5. Include endpoints None	8982
6. Filter based on genotype QC (FinnGen only)	8982

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	N14_FEMALE_GENITAL_HSIL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N871\|N872\|N891\|N892\|N901\|N902\|D06[0-9]\|D071\|D072
HD_ICD_9	6221B\|6221C\|2331A\|2333A\|6230B\|6230C\|2333B
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N871\|N872\|N891\|N892\|N901\|N902\|D06[0-9]\|D071\|D072
COD_ICD_9	6221B\|6221C\|2331A\|2333A\|6230B\|6230C\|2333B
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to HSIL lesion of the cervix uteri, vagina or vulva based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	57280	57280	-
Only index persons	55872	55872	-
Unadjusted period prevalence (%)
Whole population	1.64	1.64	-
Only index persons	2.05	2.05	-
Median age at first event (years)
Whole population	-	35.16	-
Only index persons	-	35.02	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8982	8982	-
Unadjusted period prevalence (%)	3.06	3.06	-
Median age at first event (years)	35.60	35.60	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7974: Matched controls
79740

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D06.0

ICD-10 Finland

Carcinoma in situ: Endocervix

+∞

323.0

381

C539, 6666, 0

ICD-O-3

197.8

323.0

1123

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

14.4

323.0

4930

8065

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

24.8

323.0

4413

3801

LDA10

NOMESCO Finland

Curettage of cervix uteri

18.8

323.0

2523

1912

A63.0

ICD-10 Finland

Anogenital (venereal) warts

5.7

323.0

1068

2117

LEB00

NOMESCO Finland

Biopsy of vagina

12.1

323.0

635

565

N87.0

ICD-10 Finland

Mild cervical dysplasia

9.2

323.0

1114

1388

N87.2

ICD-10 Finland

Severe cervical dysplasia, not elsewhere classified

13792.4

323.0

3796

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

34.1

323.0

5864

6007

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

116.1

323.0

4929

1093

ULA02

NOMESCO Finland

Kolposcopy

43.6

323.0

6177

5822

N87.1

ICD-10 Finland

Moderate cervical dysplasia

15476.4

323.0

3560

8077/2-C53.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of cervix uteri

378.8

323.0

2296

ZXC00

NOMESCO Finland

Use of diathermy

36.1

302.9

395

115

8070/2-C53.9

ICD-O-3

Squamous cell carcinoma in situ, NOS, of cervix uteri

73.5

283.7

325

N90.2

ICD-10 Finland

Severe vulvar dysplasia, not elsewhere classified

+∞

278.8

266

N89.1

ICD-10 Finland

Moderate vaginal dysplasia

2485.7

260.6

251

D06.1

ICD-10 Finland

Carcinoma in situ: Exocervix

+∞

254.5

243

N90.1

ICD-10 Finland

Moderate vulvar dysplasia

+∞

247.1

236

8326

FHL

Batch conization

79.5

243.4

276

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

7.2

239.3

616

918

6221C

ICD-9 Finland

Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI GRAVIS]

+∞

217.7

208

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.1

207.5

4034

26300

N89.2

ICD-10 Finland

Severe vaginal dysplasia, not elsewhere classified

+∞

191.4

183

6221B

ICD-9 Finland

Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI MODERATA]

+∞

184.0

176

LEB30

NOMESCO Finland

Destruction of lesion of vaginal mucosa

22.3

183.6

272

126

LDB20

NOMESCO Finland

Electrocoagulation or laser therapy of cervix uteri

10.7

182.3

366

358

8140/2-C53.9

ICD-O-3

Adenocarcinoma in situ, NOS, of cervix uteri

382.0

150.6

151

G01AA10

ATC

clindamycin; vaginal

2.0

139.6

2176

12407

8077/2-C51.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of vulva, NOS

+∞

135.8

130

R87.5

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal microbiological findings

6.3

132.3

370

610

8077/2-C53.1

ICD-O-3

Squamous intraepithelial neoplasia, high grade of exocervix

438.1

130.3

130

D06.9

ICD-10 Finland

Carcinoma in situ: Cervix, unspecified

1196.5

121.2

118

8077/2-C52.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of vagina, NOS

1165.6

118.1

115

N87.9

ICD-10 Finland

Dysplasia of cervix uteri, unspecified

15.1

111.3

189

128

D07.1

ICD-10 Finland

Carcinoma in situ: Vulva

1073.0

108.7

106

2331A

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Cervix uteri

+∞

99.1

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

7.4

94.2

233

323

N89.0

ICD-10 Finland

Mild vaginal dysplasia

14.0

88.2

154

112

LFC00

NOMESCO Finland

Partial excision of vulva

27.0

84.1

117

N90.0

ICD-10 Finland

Mild vulvar dysplasia

15.7

74.7

124

R87.2

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of other drugs, medicaments and biological substances

26.2

72.2

101

X86

ICPC

Abnormal cervix smear

4.9

68.4

236

498

LDC00

NOMESCO Finland

Conisation of cervix uteri using knife

51.1

67.3

LCA06

NOMESCO Finland

Biopsy of endometrium

1.8

67.2

1382

8369

LFB20

NOMESCO Finland

Destruction of lesion of vulva or perineum

7.0

67.2

171

248

R87.7

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal histological findings

9.6

65.5

137

145

R87.1

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of hormones

34.9

63.9

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

59.0

2549

18755

P01AB01

ATC

metronidazole; oral, rectal

1.5

58.3

3432

26991

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.4

57.8

524

2267

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

56.5

1379

8745

D06BB10

ATC

imiquimod; topical

2.6

53.4

427

1727

D06BB04

ATC

podophyllotoxin; topical

2.1

52.0

676

3446

C53.11

ICD-10 Finland

Squamous cell carcinoma and exocervix

16.9

51.1

Z3231

NOMESCO Finland

Registered nurse

1.5

42.5

1757

12615

Z3232

NOMESCO Finland

Midwife

1.6

39.9

1296

8780

8070/3-C53.9

ICD-O-3

Squamous cell carcinoma, NOS, of cervix uteri

16.3

38.9

Z2221

NOMESCO Finland

Medical doctor

1.4

38.0

2234

17143

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.6

35.4

1162

7870

C53.01

ICD-10 Finland

Squamous cell carcinoma of the endocervix

14.0

35.0

TLC02

NOMESCO Finland

Simple extraction of IUD

1.9

34.6

575

3196

8140/2-C53.0

ICD-O-3

Adenocarcinoma in situ, NOS, of endocervix

+∞

32.3

WX110

NOMESCO Finland

Local anesthesy

1.3

32.0

5403

48653

8140/2-C53.1

ICD-O-3

Adenocarcinoma in situ, NOS, of exocervix

+∞

31.3

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

30.8

2179

17144

C53.02

ICD-10 Finland

Adenocarcinoma of the endocervix

14.1

30.5

N07BA03

ATC

varenicline; oral

2.0

29.6

411

2143

SPAT1193

SPAT

Pap smear

1.5

29.1

1278

9192

R2110

NOMESCO Finland

Giving the first information

1.7

28.6

684

4253

LDB00

NOMESCO Finland

Excision of lesion of cervix uteri

3.1

28.6

159

514

O34.4

ICD-10 Finland

Maternal care for other abnormalities of cervix

8.6

28.3

N87

ICD-10 Finland

Dysplasia of cervix uteri

15.6

27.6

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

27.3

1830

14214

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

27.3

1251

9067

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

2.5

26.9

222

914

R87.9

ICD-10 Finland

Abnormal findings in specimens from female genital organs, unspecified abnormal finding

8.4

26.7

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

26.4

695

4438

8325

FHL

Coagulation, cryo or laser in anesthesia or operating room

7.3

25.8

N76.0

ICD-10 Finland

Acute vaginitis

1.6

24.8

723

4733

X23

ICPC

Fear sexually transm dis female

1.6

24.7

611

3836

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.6

24.4

648

4143

0781C

ICD-9 Finland

Other diseases due to viruses and Chlamydiae, Viral warts[CONDYLOMA ACCUMINATUM]

4.4

23.8

204

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.5

23.6

837

5732

8076/3-C53.9

ICD-O-3

Squamous cell carcinoma, microinvasive of cervix uteri

46.8

23.3

8071/2-C51.9

ICD-O-3

Differentiated intraepithelial neoplasia of vulva, NOS

+∞

22.9

8070/3-C51.9

ICD-O-3

Squamous cell carcinoma, NOS, of vulva, NOS

25.9

22.6

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

2.1

22.3

271

1338

A63.8

ICD-10 Finland

Other specified predominantly sexually transmitted diseases

7.4

22.3

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

22.0

210

933

G01AF01

ATC

metronidazole; vaginal

1.5

21.7

838

5845

X92

ICPC

Chlamydia infection genital female

2.6

21.6

162

636

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

21.2

421

2480

8070/2-C51.9

ICD-O-3

Squamous cell carcinoma in situ, NOS, of vulva, NOS

+∞

20.8

8140/3-C53.9

ICD-O-3

Adenocarcinoma, NOS, of cervix uteri

14.4

19.8

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

19.7

614

4080

LCH11

NOMESCO Finland

Pharmacologic abortion

1.6

19.6

532

3414

N02AX02

ATC

tramadol; systemic, rectal

1.3

19.6

2346

19650

M03BX02

ATC

tizanidine; oral

1.2

19.4

4792

43651

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

2.0

19.3

240

1202

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

18.6

984

7288

N02BE01

ATC

paracetamol; systemic, rectal

1.3

18.2

6313

59583

C51.11

ICD-10 Finland

Squamous cell carcinoma of the labium minus

21.7

18.1

SPAT1283

SPAT

Restricted health certificate

1.3

18.0

1858

15234

C51.01

ICD-10 Finland

Squamous cell carcinoma of the labium majus

18.1

17.7

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

1.8

17.7

334

1937

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

17.5

418

2597

LCD10

NOMESCO Finland

Vaginal hysterectomy

1.9

17.4

269

1461

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

17.0

3095

27100

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

2.2

16.9

173

797

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

1.7

16.9

330

1936

SPAT1308

SPAT

Sexual health counselling

1.3

16.7

1457

11663

D07.2

ICD-10 Finland

Carcinoma in situ: Vagina

+∞

16.7

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

16.3

2175

18363

J01DB01

ATC

cefalexin; oral

1.3

16.2

6176

58343

J02AC01

ATC

fluconazole; systemic

1.2

16.2

3863

34724

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.5

16.1

567

3870

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

16.1

2732

23698

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

16.0

5582

52155

M54.5

ICD-10 Finland

Low back pain

1.2

16.0

2332

19887

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

15.7

7159

69051

8010/2-C53.9

ICD-O-3

Carcinoma in situ, NOS, of cervix uteri

+∞

15.6

W11

ICPC

Contraception oral

1.4

15.3

950

7212

Z30.4

ICD-10 Finland

Surveillance of contraceptive drugs

1.4

15.3

730

5297

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

1.7

15.2

308

1828

R87.3

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of substances chiefly nonmedicinal as to source

23.4

15.1

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

15.0

189

953

J01CA08

ATC

pivmecillinam; oral

1.2

14.9

3806

34328

Z72.0

ICD-10 Finland

Tobacco use

2.1

14.7

164

785

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

14.6

1570

12892

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

7.3

14.4

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

1.7

14.0

288

1718

Z5132

NOMESCO Finland

Nursing associate professional

4.5

14.0

106

N90.3

ICD-10 Finland

Dysplasia of vulva, unspecified

30.1

13.9

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

3.7

13.8

165

LCD31

NOMESCO Finland

Radical laparoscopic hysterectomy

8.6

13.7

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

1.3

13.6

1490

12243

6230B

ICD-9 Finland

Noninflammatory disorders of vagina, Dysplasia of vagina[DYSPLASIA VAGINAE MODERATA]

+∞

13.5

N05CF01

ATC

zopiclone; oral

1.2

13.4

1711

14314

N06AX11

ATC

mirtazapine; oral

1.2

13.3

2056

17574

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

2.8

13.2

297

4044

NOMESCO Finland

12.1

13.1

WX002

NOMESCO Finland

Sedation and analgesia

1.3

13.0

950

7393

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

12.9

2399

20880

SPAT1263

SPAT

Sampling

1.2

12.9

2904

25748

N93.0

ICD-10 Finland

Postcoital and contact bleeding

2.6

12.9

362

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

12.6

1544

12841

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

12.5

4047

37050

2333B

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Other and unspecified female genital organs[CARCINOMA IN SITU VULVAE]

+∞

12.5

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.6

12.4

313

1976

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

12.2

3623

32890

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.6

12.1

282

1747

LFD10

NOMESCO Finland

Vulvectomy and excision of regional lymph nodes

46.7

11.9

WX290

NOMESCO Finland

Other blockade of nerve

1.2

11.9

3593

32644

J01AA02

ATC

doxycycline; systemic

1.2

11.8

5531

52183

R87.0

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of enzymes

5.6

11.7

J05AB01

ATC

aciclovir; systemic

1.2

11.6

1450

12080

SPAT1312

SPAT

General health counselling

1.2

11.6

2167

18833

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

11.5

2843

25347

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

11.5

2689

23866

C53.12

ICD-10 Finland

Adenocarcinoma of the exocervix

13.6

11.4

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.3

11.4

1034

8279

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.2

11.4

109

493

X15

ICPC

Vaginal symptom/complaint other

1.5

11.3

349

2316

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

11.3

1389

11552

K02.1

ICD-10 Finland

Caries of dentine

1.2

11.2

4376

40530

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

1.9

11.1

163

875

ZXC10

NOMESCO Finland

Use of laser

2.1

10.9

123

598

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.5

10.8

315

2061

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

10.8

2163

18895

8474

FHL

Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia

3.8

10.8

116

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.9

10.7

112

8070/3-C53.1

ICD-O-3

Squamous cell carcinoma, NOS, of exocervix

17.8

10.7

EBA00

NOMESCO Finland

Extraction of tooth

1.2

10.7

2039

17727

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

10.7

159

858

LBE20

NOMESCO Finland

Laparoscopic bilateral salpingectomy

1.8

10.6

167

920

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.2

10.6

1604

13627

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

10.6

2376

20968

W14

ICPC

Contraception female other

1.4

10.6

510

3707

L04AX01

ATC

azathioprine; systemic

1.6

10.5

258

1618

D82

ICPC

Teeth/gum disease

1.2

10.5

2618

23314

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

10.5

3817

35077

R74

ICPC

Upper respiratory infection acute

1.2

10.4

2521

22384

LEB10

NOMESCO Finland

Excision of lesion of vagina

3.1

10.3

179

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

10.3

1934

16775

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

1.7

10.3

197

1155

C51.81

ICD-10 Finland

Squamous cell carcinoma of the vulva

18.8

10.2

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

10.2

1007

8150

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

10.2

2666

23826

6350C

ICD-9 Finland

Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]

1.4

10.1

415

2932

8327

FHL

Amputation portionis and conization

40.1

10.0

T74.1

ICD-10 Finland

Physical abuse

1.9

9.9

145

781

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

9.9

5343

50547

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

3.8

9.8

106

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.6

9.8

258

1653

L04AA06

ATC

mycophenolic acid; systemic

2.3

9.7

377

X85

ICPC

Cervical disease NOS

6.8

9.6

N90.4

ICD-10 Finland

Leukoplakia of vulva

3.9

9.6

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

9.5

3892

35968

C53.00

ICD-10 Finland

Malignant tumor of endocervix without histology

10.0

9.5

M79.6

ICD-10 Finland

Pain in limb

1.2

9.4

2255

19965

8077/2-C53.0

ICD-O-3

Squamous intraepithelial neoplasia, high grade of endocervix

+∞

9.4

D06.7

ICD-10 Finland

Carcinoma in situ: Other parts of cervix

+∞

9.4

A02BC02

ATC

pantoprazole; systemic

1.2

9.4

4077

37841

M01AB05

ATC

diclofenac; systemic, rectal

1.2

9.4

4635

43437

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

9.3

2565

22968

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

2.5

9.2

290

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

3.5

9.1

114

R87.8

ICD-10 Finland

Abnormal findings in specimens from female genital organs, other abnormal findings

3.2

9.0

141

7950A

ICD-9 Finland

Nonspecific abnormal histological and immunological findings, Nonspecific abnormal Papanicolaou smear of cervix

7.0

9.0

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.3

9.0

600

4606

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

9.0

1661

14367

SPAT1301

SPAT

No procedures

1.2

8.9

1790

15595

J01DA01

ATC

[U] cefalexin; systemic

1.2

8.9

4538

42544

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.3

8.8

632

4895

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

8.8

1743

15168

N06AB04

ATC

citalopram; systemic

1.2

8.7

1394

11884

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

8.7

1112

9261

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.3

8.7

660

5157

J01MA02

ATC

ciprofloxacin; systemic

1.2

8.7

2025

17869

LDA96

NOMESCO Finland

Other biopsy of cervix uteri

14.0

8.7

B01AB10

ATC

tinzaparin; parenteral

1.5

8.7

310

2131

WF002

NOMESCO Finland

Radical radiotherapy

1.9

8.6

116

607

L03

ICPC

Low back symptom/complaint

1.2

8.6

1544

13308

N93.8

ICD-10 Finland

Other specified abnormal uterine and vaginal bleeding

1.8

8.6

147

836

O04.6

ICD-10 Finland

Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage

1.9

8.6

120

639

AA1AD

NOMESCO Finland

CT of head and brain

1.3

8.5

894

7286

N05BA04

ATC

oxazepam; oral

1.2

8.4

1593

13794

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.4

8.4

303

8542/3-C51.9

ICD-O-3

Paget disease, extramammary of vulva, NOS

90.1

8.4

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

1.6

8.3

225

1452

XLA10

NOMESCO Finland

1.4

8.3

410

2997

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

8.2

2668

24141

J05AB11

ATC

valaciclovir; oral

1.3

8.2

806

6511

H02AB06

ATC

prednisolone; systemic

1.2

8.2

2846

25879

SPAT1192

SPAT

Gynaecological examination

1.2

8.2

1115

9345

J01FF01

ATC

clindamycin; systemic

1.2

8.1

1586

13766

M01AH05

ATC

etoricoxib; oral

1.1

8.1

3987

37172

X14

ICPC

Vaginal discharge

1.6

8.1

216

1395

Z30.2

ICD-10 Finland

Sterilization

1.2

8.0

919

7561

ZXC96

NOMESCO Finland

Robot assisted procedure

2.3

8.0

321

M54

ICD-10 Finland

Dorsalgia

1.3

8.0

735

5897

X91

ICPC

Condylomata acuminata female

3.2

7.9

122

R51.80

ICD-10 Finland

Headache

1.2

7.9

1084

9093

8140/3-C53.0

ICD-O-3

Adenocarcinoma, NOS, of endocervix

13.0

7.9

SPAT1153

SPAT

Removal of sutures

1.2

7.8

1561

13577

Z87.4

ICD-10 Finland

Personal history of diseases of the genitourinary system

2.1

7.8

409

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.3

7.8

651

5155

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

1.2

7.7

1400

12072

SPAT1254

SPAT

Administration of medicine

1.3

7.7

609

4790

O34.3

ICD-10 Finland

Maternal care for cervical incompetence

2.4

7.7

267

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

7.4

7.7

Z09.9

ICD-10 Finland

Follow-up examination after unspecified treatment for other conditions

2.0

7.6

498

LDB10

NOMESCO Finland

Cryotherapy of cervix uteri

3.1

7.6

127

A03

ICPC

Fever

1.2

7.6

1183

10059

D11

ICPC

Diarrhoea

1.2

7.5

821

6721

N06AX16

ATC

venlafaxine; oral

1.2

7.4

1018

8539

M77.1

ICD-10 Finland

Lateral epicondylitis

1.3

7.4

500

3843

127

Kela drug reimbursment

Transplant complication

2.4

7.4

255

LCH13

NOMESCO Finland

Vacuum aspiration from uterus after medically induced abortion

1.6

7.4

177

1111

M54.4

ICD-10 Finland

Lumbago with sciatica

1.2

7.4

1002

8396

ZX095

NOMESCO Finland

Combined chemoradiotherapy

3.3

7.4

102

D07AD01

ATC

clobetasol; topical

1.2

7.4

831

6828

ZXE00

NOMESCO Finland

One hour or less

1.1

7.3

2706

24666

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

7.3

517

4001

1390

FHL

Colposcopy

4.3

7.3

T810, N872

ICD-10 Finland

+∞

7.3

6230C

ICD-9 Finland

Noninflammatory disorders of vagina, Dysplasia of vagina[DYSPLASIA VAGINAE GRAVIS]

+∞

7.3

8111

FHL

Taking a biopsy from the mouth of the uterus at the operating room or under anesthesia (vulvabiopsia 8474, vaginabiopsia 8411)

4.5

7.2

D10

ICPC

Vomiting

1.3

7.2

467

3568

C53.10

ICD-10 Finland

Malignant tumor of the exocervix without histology

15.7

7.2

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

1.6

7.2

167

1041

LCD30

NOMESCO Finland

Radical hysterectomy

5.8

7.2

P17

ICPC

Tobacco abuse

2.0

7.1

454

8070/3-C52.9

ICD-O-3

Squamous cell carcinoma, NOS, of vagina, NOS

20.0

7.1

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

7.1

293

2076

Z71.8

ICD-10 Finland

Other specified counselling

1.2

7.1

1668

14693

YX9VG

NOMESCO Finland

Other MRI eamination with high intensity magnet for dose design of radiotherapy

7.9

7.1

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.1

7.1

347

J01EA01

ATC

trimethoprim; systemic

1.2

7.0

1803

15991

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

7.0

1129

9618

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.3

7.0

469

3602

ULC02

NOMESCO Finland

Hysteroscopy

1.4

7.0

395

2957

R21

ICPC

Throat symptom/complaint

1.2

7.0

1673

14755

N30.0

ICD-10 Finland

Acute cystitis

1.2

7.0

891

7416

TAC99

NOMESCO Finland

Other blockade for chronic pain

2.9

6.9

139

N02AA05

ATC

oxycodone; systemic

1.3

6.9

445

3402

N72

ICD-10 Finland

Inflammatory disease of cervix uteri

2.1

6.9

336

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

6.8

1301

11255

LDC10

NOMESCO Finland

Partial excision of cervix uteri

8.2

6.8

SAA02

NOMESCO Finland

Basic examination of mouth

1.1

6.8

5057

48168

D01

ICPC

Abdominal pain/cramps general

1.3

6.8

685

5558

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

4.1

6.8

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

6.7

593

4730

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

6.7

1957

17514

LFC96

NOMESCO Finland

Other partial excision of vulva or perineum

16.7

6.7

N89.3

ICD-10 Finland

Dysplasia of vagina, unspecified

16.7

6.7

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.3

6.7

498

3882

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

0.8

6.7

861

10200

A11CC03

ATC

alfacalcidol; systemic

2.1

6.7

343

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.2

6.7

1050

8924

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

6.7

1803

16045

LFD00

NOMESCO Finland

Vulvectomy

22.5

6.7

M01AE02

ATC

naproxen; oral, rectal

1.1

6.7

4100

38568

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

0.8

6.7

411

5276

WX402

NOMESCO Finland

General anaesthesia

1.2

6.7

981

8290

L04AA01

ATC

[U] ciclosporin; systemic

2.1

6.6

362

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.2

6.6

966

8153

B02AA02

ATC

tranexamic acid; systemic

1.2

6.6

1258

10881

LWA00

NOMESCO Finland

Repair of wound dehiscence in gynaecological surgery

4.6

6.6

C51.9

ICD-10 Finland

Malignant neoplasm: Vulva, unspecified

8.7

6.5

SPAT1249

SPAT

Treatment-related counselling outside office

1.1

6.5

2736

25107

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.2

6.5

694

5664

N03AX12

ATC

gabapentin; oral

1.2

6.5

795

6588

O04.1

ICD-10 Finland

Medical abortion, incomplete, complicated by delayed or excessive haemorrhage

1.9

6.5

504

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

2.7

6.5

157

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

2.8

6.5

135

X29

ICPC

Genital sympt/compl female other

1.8

6.4

111

636

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.2

6.4

893

7501

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.2

6.4

261

C53.09

ICD-10 Finland

Malignant tumor of endocervix, unspecified histology

14.3

6.4

C51.00

ICD-10 Finland

Malignant tumor of the labium majus without histology

14.3

6.4

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.2

6.4

673

5488

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.2

6.4

668

5441

N97.2

ICD-10 Finland

Female infertility of uterine origin

3.9

6.4

8411

FHL

Local change laser, coagulation, biopsy or removal

3.6

6.4

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

6.3

1305

11362

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.2

6.3

263

J01FA10

ATC

azithromycin; systemic

1.1

6.3

4532

42967

KAY40

NOMESCO Finland

0.6

6.3

1275

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

1.5

6.3

179

1175

4750B

ICD-9 Finland

Peritonsillar abscess[PERITONSILLITIS ABSCEDENS]

2.1

6.3

324

P01BA02

ATC

hydroxychloroquine; oral

1.3

6.3

471

3682

LWW96

NOMESCO Finland

Other reoperation in gynaecological surgery

3.7

6.2

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

3.7

6.2

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.3

6.2

421

3243

8070/3-C51.1

ICD-O-3

Squamous cell carcinoma, NOS, of labium minus

26.7

6.2

7020X

ICD-9 Finland

Other dermatoses, Actinic keratosis[DERMATOSES PRAECANCEROSAE ALIAE]

26.7

6.2

N05CF02

ATC

zolpidem; oral

1.2

6.2

1110

9547

ZXE20

NOMESCO Finland

More than three and less than five hours

1.3

6.2

549

4386

R05

ICPC

Cough

1.2

6.1

1378

12079

SDA05

NOMESCO Finland

Very demanding and lengthy parodonthologic therapy

1.4

6.1

268

1925

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

6.1

519

4121

A12AA04

ATC

calcium carbonate; oral

2.4

6.1

195

128

Kela drug reimbursment

Cancers of female genital organs

1.9

6.1

455

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

6.1

201

1368

R42

ICD-10 Finland

Dizziness and giddiness

1.2

6.0

1021

8737

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.1

6.0

4339

41085

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

1.6

6.0

153

981

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

5117

32962

2.28

309.10

2.9

1.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2002

4937

4.93

307.65

2.3

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

706

442

17.25

307.65

2.5

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

5087

24614

3.46

307.65

2.4

1.4

—

(3025130) Human papilloma virus identified in Specimen

1661

1834

10.88

307.65

2.4

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2748

18521

1.70

105.74

2.4

2.0

—

(4035726)

1061

5365

2.11

100.65

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2474

16457

1.69

98.64

2.3

2.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

116

162

7.24

78.53

1.7

2.1

ug/l

7.7

2.7

0.59

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1712

12420

1.47

40.75

2.0

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1345

9481

1.49

36.59

1.8

1.7

—

(3002256) Pathology report gross observation

1327

9922

1.40

25.46

1.3

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

5800

53153

1.26

22.51

4.3

4.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5606

51303

1.25

21.41

4.2

3.9

e6/l

2205.3

1917.6

0.09

555

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

791

5671

1.43

19.00

1.6

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

2761

23685

1.24

18.28

2.2

2.0

—

(42870588) Differential panel, method unspecified - Blood

2741

23661

1.23

16.76

6.3

5.8

—

(3009261) Glucose [Presence] in Urine by Test strip

4286

38697

1.21

16.49

3.5

3.3

estimate

0.0

2.96

850

7583

(3013707) Erythrocyte sedimentation rate by Westergren method

6008

56042

1.22

16.33

4.1

3.8

mm/h

9.9

10.0

0.11

5656

52835

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5749

53395

1.21

16.33

7.2

6.7

u/l

71.9

72.7

0.97

5421

50458

(3021601) Nitrite [Presence] in Urine by Test strip

4253

38437

1.20

15.99

4.7

4.5

estimate

0.0

0.04

863

7686

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8024

77430

1.34

15.81

11.7

10.4

mg/l

18.9

18.5

0.54

6226

59524

(46235355) HIV 1 and 2 tests - Meaningful Use set

2910

25414

1.21

15.58

2.1

2.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4132

37336

1.20

15.30

3.9

3.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

7724

74268

1.29

14.70

11.3

10.2

mmol/l

3.9

0.26

7495

72173

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2055

17443

1.23

14.35

2.1

1.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

7696

74055

1.27

13.93

11.2

10.1

mmol/l

139.5

139.6

1.81

7484

72141

(3035350) Ketones [Presence] in Urine by Test strip

4204

38256

1.19

13.79

3.4

3.3

estimate

0.0

0.03

836

7449

(3006315) Basophils [#/volume] in Blood

4123

37513

1.18

13.40

6.1

5.6

e9/l

0.0

0.21

3659

33171

(3001604) Monocytes [#/volume] in Blood

4099

37379

1.18

12.70

6.1

5.6

e9/l

0.5

0.46

3660

33140

(3018095) Leukocytes [#/volume] in Urine

2738

24128

1.19

12.67

3.5

3.2

e6/l

55.2

76.8

1.76

1783

15640

(3006504) Eosinophils/100 leukocytes in Blood

3854

35073

1.17

11.99

6.2

5.7

2.7

2.8

0.86

3614

32851

(3019069) Monocytes/100 leukocytes in Blood

3870

35246

1.17

11.89

6.5

5.9

7.9

0.32

3654

33303

(3013115) Eosinophils [#/volume] in Blood

4238

38925

1.17

11.58

6.3

5.8

e9/l

0.2

0.00

3839

35064

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1037

8332

1.28

11.53

2.2

u/l

4120.6

5958.2

1.30

407

3463

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7259

69755

1.21

11.18

9.7

8.9

ml/min/173m2

91.1

91.0

0.19

5941

57013

(3030467) Casts [#/volume] in Urine by Automated count

1990

17200

1.20

11.14

3.0

2.7

e6/l

0.3

0.08

1457

12545

(3022096) Basophils/100 leukocytes in Blood

3716

33850

1.17

11.13

6.4

5.7

0.7

0.42

3473

31719

(3013650) Neutrophils [#/volume] in Blood by Automated count

4626

42863

1.16

11.07

8.6

8.4

e9/l

4.0

3.9

0.76

4111

37924

(3019198) Lymphocytes [#/volume] in Blood

4222

38862

1.16

10.98

6.1

5.6

e9/l

2.0

0.08

3827

35150

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1225

10093

1.25

10.97

2.6

2.4

e6/l

1.0

1.2

0.94

668

5405

(3018010) Neutrophils/100 leukocytes in Blood

3955

36235

1.16

10.91

6.0

5.5

56.6

56.5

0.22

3722

34213

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3750

34255

1.16

10.68

5.5

5.3

umol/l

9.2

9.6

2.16

3519

32272

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8265

80648

1.31

10.66

9.4

8.6

u/l

23.7

23.9

0.21

8033

78468

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2992

26871

1.17

10.58

5.2

4.7

mmol/l

1.2

0.82

2705

24594

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3326

30145

1.16

10.41

6.0

5.4

mmol/l

1.2

1.32

2816

25547

(3002030) Lymphocytes/100 leukocytes in Blood

3993

36702

1.16

10.35

6.3

5.6

29.6

29.7

0.46

3750

34552

(3011288) Drugs identified in Urine by Screen method

451

3282

1.39

9.95

4.0

2.5

—

(3026008) Bacteria identified in Urine by Culture

2430

21552

1.17

9.91

2.6

2.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2969

26771

1.16

9.78

4.6

4.2

g/l

36.6

36.7

0.07

2793

24982

(36304419) Bacteria [Presence] in Urine

1980

17305

1.18

9.58

2.9

2.6

—

(3002582) Erythrocytes [#/volume] in Urine

2150

18926

1.18

9.55

3.0

2.8

e6/l

36.5

72.9

1.80

1600

14055

(3011397) Hemoglobin [Presence] in Urine by Test strip

1978

17291

1.18

9.54

3.4

3.3

—

(3033658) Prothrombin time (PT) actual/Normal

1906

16620

1.19

9.46

3.7

3.3

98.1

98.3

0.17

1849

16100

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1126

9427

1.22

8.58

2.7

2.5

e6/l

4.7

5.0

0.30

571

4767

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

846

6894

1.25

8.29

4.9

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

811

6577

1.26

8.29

2.3

2.8

u/ml

45.9

38.2

0.19

785

6352

(3029937) Albumin [Presence] in Urine by Test strip

2263

20193

1.16

8.27

3.8

3.6

estimate

0.0

0.01

865

7604

(40761511) CBC panel - Blood by Automated count

8368

82063

1.29

8.24

10.8

9.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5763

54827

1.14

8.12

3.0

2.7

u/l

36.0

34.1

1.17

5502

52424

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2761

25029

1.15

8.08

1.8

pmol/l

99.7

99.6

0.06

1494

13214

(3028707) Methadone [Presence] in Urine by Screen method

291

2043

1.44

7.94

3.4

2.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7624

74127

1.19

7.70

5.1

mu/l

1.7

2.0

3.92

7197

70468

(3016879) Cocaine [Presence] in Urine

554

4327

1.30

7.68

2.8

1.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1426

12351

1.18

7.49

1.7

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

438

1.93

7.43

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2358

21283

1.15

7.18

2.5

2.4

u/l

53.3

56.7

4.39

2184

19781

(3000764) Benzodiazepines [Presence] in Urine

593

4723

1.27

7.07

2.7

1.8

—

(3028300) Cannabinoids [Presence] in Urine

597

4763

1.27

7.02

2.7

1.8

—

(3021589) Normoblasts [#/volume] in Blood

3570

33143

1.13

6.96

8.6

8.0

e9/l

0.0

2.54

2959

27230

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1170

10025

1.19

6.93

1.7

1.6

1.4

1.3

2.76

1032

9077

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1781

15795

1.16

6.90

1.3

u/ml

10.9

9.2

0.50

677

6795

(3027008) Opiates [Presence] in Urine

594

4747

1.27

6.90

2.3

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

468

3629

1.31

6.88

3.0

1.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

4069

38167

1.12

6.51

4.1

3.8

mmol/l

6.3

0.72

3678

34394

(3007461) Platelets [#/volume] in Blood

8778

86898

1.45

6.33

17.4

15.7

e9/l

269.3

269.0

0.17

8627

85368

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6837

66173

1.14

6.29

4.5

4.4

pmol/l

14.3

0.28

6409

62361

(3032080) INR in Blood by Coagulation assay

2298

20864

1.14

6.27

5.7

5.4

inr

1.1

0.06

734

6927

(3026782) Osmolality of Urine

1374

12030

1.17

6.26

2.8

2.5

mosm/kgh2o

516.3

521.0

0.32

1168

10184

(3035941) MCH [Entitic mass]

8783

86964

1.45

6.24

17.3

15.6

30.2

30.0

32.08

8703

86235

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1920

17232

1.15

6.23

1.9

2.0

u/l

171.4

141.3

0.57

1823

16332

(3024731) MCV [Entitic volume]

8783

86966

1.45

6.22

17.3

15.7

90.8

90.2

29.43

8701

86240

(3026361) Erythrocytes [#/volume] in Blood

8783

86976

1.44

6.11

17.4

15.7

e12/l

4.4

4.5

14.29

8622

85346

(3010813) Leukocytes [#/volume] in Blood

8784

86996

1.44

6.02

17.4

15.8

e9/l

6.8

6.7

5.01

8625

85313

(3007853) Bacteria identified in Skin by Aerobe culture

978

8359

1.19

5.95

1.7

1.6

—

(3027944) Amphetamines [Presence] in Urine

578

4695

1.25

5.87

2.6

1.8

—

(3000963) Hemoglobin [Mass/volume] in Blood

8784

87010

1.43

5.86

17.5

15.8

g/l

132.9

0.12

8704

86275

(3000850) Epithelial cells [#/volume] in Urine

1490

13213

1.15

5.70

2.5

2.3

e6/l

9.0

8.5

0.38

1281

11431

(40758558) Short blood count panel - Blood

2018

18268

1.13

5.69

6.4

6.3

—

(3018418) pH of Serum or Plasma

1995

18056

1.13

5.64

4.0

3.5

7.4

0.43

376

3451

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

661

5476

1.22

5.59

4.3

3.8

u/l

228.4

231.8

0.32

626

5188

(3000991) Gas panel - Venous blood

463

3691

1.27

5.54

8.8

7.4

—

(3019225) pH of Specimen

674

5606

1.22

5.49

3.3

3.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1003

8652

1.18

5.48

1.8

1.7

—

(3045414) Leukocytes [Presence] in Urine

434

3441

1.27

5.44

1.6

1.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1821

16443

1.13

5.30

1.3

iu/ml

43.0

29.8

0.34

561

5148

(3037522) Nuclear Ab [Titer] in Serum

1426

12672

1.15

5.27

1.4

titre

577.7

567.4

0.07

301

2580

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3221

30079

1.11

5.22

3.6

3.3

—

(3042936) Bacteria identified in Isolate by Culture

1002

8680

1.17

5.20

1.9

1.8

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.13

5.18

1.4

—

(3044889) 12 lead EKG panel

4846

46225

1.11

5.14

2.9

2.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

353

2748

1.30

5.13

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

264

1974

1.35

5.10

2.2

1.9

g/l

1.5

1.4

0.92

225

1716

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

627

5238

1.21

4.91

2.4

2.2

g/l

0.2

1.54

587

4959

(3027801) Oxygen [Partial pressure] in Arterial blood

592

4919

1.22

4.89

6.6

6.4

kpa

13.2

13.7

1.22

563

4695

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

592

4921

1.22

4.88

6.6

6.4

kpa

5.0

0.14

565

4703

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

858

7384

1.18

4.83

3.2

3.5

33.0

32.8

0.21

660

5497

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1050

9183

1.16

4.83

3.2

3.0

mmol/l

0.8

1.57

989

8592

(3015377) Calcium [Moles/volume] in Serum or Plasma

2406

22196

1.11

4.81

3.1

mmol/l

2.3

0.34

2151

19947

(3019150) Specific gravity of Urine by Refractometry

1796

16299

1.13

4.78

3.6

3.5

kg/l

1.0

0.18

260

2503

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

285

1.90

4.75

1.3

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

622

1.60

4.74

1.3

u/ml

18.6

60.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

524

4322

1.23

4.67

1.4

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

491

4026

1.23

4.63

7.3

7.1

g/l

119.8

120.6

0.39

478

3868

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

610

1.60

4.63

1.3

u/ml

70.7

54.1

0.33

(3016502) Oxygen saturation in Arterial blood

513

4226

1.23

4.63

6.9

96.2

96.3

0.18

494

4051

(3045424) Erythrocytes [Presence] in Urine

176

1253

1.41

4.62

1.3

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

611

1.59

4.61

1.3

u/ml

37.8

47.4

0.22

(3003396) Base excess in Arterial blood by calculation

589

4933

1.21

4.51

6.6

6.4

mmol/l

0.7

0.9

0.27

442

3752

(3025941) Bacteria identified in Stool by Culture

625

5265

1.20

4.50

1.3

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

214

2.01

4.49

2.7

2.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2260

20850

1.11

4.47

2.7

2.6

ng/l

28.0

66.9

0.57

974

9166

(3014576) Chloride [Moles/volume] in Serum or Plasma

675

5731

1.19

4.46

7.0

6.1

mmol/l

104.7

104.9

0.49

663

5627

(4198724)

448

1.68

4.40

4.8

2.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

589

1.59

4.34

1.3

u/ml

4.9

6.0

0.12

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2335

21610

1.11

4.33

1.3

u/ml

1.7

1.5

0.32

681

6452

(3007164) IgA [Mass/volume] in Serum or Plasma

1967

18044

1.12

4.30

1.4

g/l

2.1

0.01

1191

11580

(3048689) Calprotectin [Mass/mass] in Stool

1350

12113

1.13

4.29

2.4

ug/g

114.6

98.8

0.83

1018

9469

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7218

70541

1.12

4.22

3.6

mmol/l

5.6

0.54

6748

66332

(3021960) Folate [Moles/volume] in Serum or Plasma

1478

13351

1.13

4.22

1.5

nmol/l

21.3

21.2

0.10

1294

11803

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

506

4206

1.22

4.21

1.7

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

895

7824

1.16

4.15

3.1

2.4

umol/l

6.0

6.1

0.08

739

6552

(3023368) Bacteria identified in Blood by Culture

1489

13470

1.13

4.14

4.1

3.7

—

(3003181) Sodium [Moles/volume] in Urine

106

700

1.52

4.13

1.6

1.4

mmol/l

54.9

66.0

1.97

552

(3020191) Ethanol [Moles/volume] in Serum or Plasma

497

1.62

4.07

1.6

promille

1.5

1.2

0.87

373

(3019309) Folate [Moles/volume] in Red Blood Cells

1084

9634

1.14

3.99

1.7

nmol/l

1155.8

1199.1

0.89

860

7599

(3019832) Treponema pallidum Ab [Presence] in Serum

1914

17607

1.11

3.94

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

197

1473

1.34

3.90

3.5

2.9

mg/l

1.4

1.3

1.02

189

1385

(3022145) Colonoscopy Study observation

882

7746

1.15

3.85

1.4

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

651

5594

1.18

3.78

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2347

21882

1.10

3.67

1.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

122

2.22

3.66

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

114

786

1.46

3.65

2.9

2.6

1.5

1.4

0.10

620

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

276

2188

1.27

3.59

9.4

8.2

mmol/l

24.1

24.2

0.12

253

2061

(3023323) Follitropin [Units/volume] in Serum or Plasma

1041

9301

1.13

3.54

1.3

iu/l

25.3

26.3

0.44

911

8155

(21494815) CD4 cells/100 lymphocytes in Specimen

612

1.51

3.53

2.2

2.0

46.3

45.4

0.10

101

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1126

10121

1.13

3.48

2.9

ng/l

217.9

300.0

0.74

598

5434

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

656

5682

1.17

3.47

1.7

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

288

2309

1.26

3.42

7.9

8.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

244

1.81

3.42

25.9

25.1

ug/l

104.2

112.1

0.43

196

(3019060) Gas panel - Arterial blood

329

2678

1.24

3.42

3.6

4.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1194

10788

1.12

3.39

2.5

mmol/l

2.4

0.13

1039

9392

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2685

25278

1.09

3.33

3.4

3.0

u/l

29.8

0.00

2550

24203

(3017732) Neutrophils [#/volume] in Blood

660

5739

1.16

3.33

2.6

2.3

e9/l

4.3

4.1

1.13

530

4852

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

622

1.48

3.29

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

1805

16707

1.10

3.25

3.5

3.1

mmol/l

7.2

7.4

0.70

1544

14414

(3020779) Urea [Moles/volume] in Serum or Plasma

446

3763

1.19

3.24

9.5

6.9

mmol/l

7.9

7.3

1.15

424

3622

(3016038) Potassium [Moles/volume] in Urine

256

1.76

3.24

1.6

1.3

mmol/l

34.9

34.1

0.07

220

(40761535) Cells panel - Urine sediment

562

4838

1.17

3.23

3.5

3.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

472

1.55

3.22

3.3

2.6

57.9

56.8

0.16

303

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

123

883

1.40

3.21

1.6

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

640

5569

1.16

3.21

2.7

2.5

g/l

10.5

10.4

0.19

584

5112

(3013512) EKG study

1685

15580

1.10

3.09

2.9

—

(3003694) ABO and Rh group [Type] in Blood

2792

26402

1.08

3.07

1.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

916

8197

1.13

3.06

2.0

2.1

29.2

29.1

0.10

891

7924

(3021447) Carbon dioxide [Partial pressure] in Venous blood

467

3980

1.18

3.05

4.3

3.5

kpa

5.8

0.10

454

3845

(3013762) Body weight Measured

5.84

3.02

1.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3425

32682

1.08

2.96

2.3

nmol/l

76.0

2756.5

0.50

3158

30583

(3002032) Base excess in Venous blood by calculation

462

3951

1.18

2.91

4.3

3.6

mmol/l

2.0

1.8

0.24

372

3213

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

298

2448

1.22

2.90

1.4

1.3

u/ml

13.4

6.9

0.65

252

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

486

1.51

2.86

2.2

1.7

99.8

101.2

0.11

432

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

617

5404

1.15

2.86

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

280

2289

1.23

2.86

2.2

2.5

g/l

3.7

3.6

0.58

254

2160

(3009542) Hematocrit [Volume Fraction] of Blood

7565

74452

1.10

2.85

12.3

11.2

39.5

0.32

6178

60887

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

342

2854

1.21

2.84

2.6

1.9

g/l

1.1

1.2

1.18

324

2730

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

330

2746

1.21

2.83

1.3

u/ml

31.3

35.4

0.17

196

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

314

1.63

2.80

2.2

2.3

umol/l

145.9

174.8

0.31

158

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

301

2485

1.22

2.80

1.4

1.3

u/ml

6.1

8.2

0.54

407

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6512

63692

1.08

2.80

4.2

4.3

mmol/mol

37.1

37.5

5.10

6122

60329

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

117

855

1.37

2.79

1.3

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.64

2.79

9.1

11.0

mmol/l

4.6

5.0

0.29

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

332

2770

1.21

2.77

2.7

2.0

g/l

0.2

0.47

312

2642

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

482

1.50

2.76

2.7

e6/l

817.5

891.2

0.34

216

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

653

5758

1.14

2.76

1.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

465

4001

1.17

2.74

7.5

6.1

mmol/l

1.3

1.2

0.10

446

3866

(3004789) Transferrin [Mass/volume] in Serum or Plasma

999

9052

1.12

2.72

2.5

2.2

g/l

2.4

2.5

2.54

897

8402

(36660697) Celiac disease serology panel - Serum

843

7567

1.13

2.70

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

175

1.83

2.67

1.1

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

175

1.83

2.67

1.1

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

120

888

1.36

2.67

3.3

2.9

umol/l

31.0

33.1

0.68

108

768

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

334

1.59

2.67

2.6

2.5

au/ml

166.2

162.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

159

1226

1.30

2.67

7.0

4.9

iu/ml

818.0

849.2

0.03

137

(3000494) Fungus identified in Specimen by Culture

902

8136

1.12

2.66

1.5

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

884

7965

1.12

2.66

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

649

5736

1.14

2.66

2.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

209

1670

1.26

2.64

1.3

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

367

3108

1.19

2.62

1.4

1.5

pmol/l

86.7

100.8

0.40

362

3034

(3028026) IgM [Mass/volume] in Serum or Plasma

493

4278

1.16

2.62

1.6

1.8

g/l

1.3

0.38

451

3967

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.90

2.58

1.1

1.2

ml/s/173m2

10.2

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

376

3198

1.18

2.57

3.6

3.0

kpa

4.7

0.03

364

3078

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1907

17873

1.09

2.56

2.2

2.1

mg/l

2.7

0.17

1628

15468

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

229

1857

1.24

2.56

1.4

1.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

261

2148

1.22

2.54

5.6

4.1

mmol/l

24.2

24.3

0.13

231

1912

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

353

2990

1.19

2.53

2.8

2.0

—

(3002385) Erythrocyte distribution width [Ratio]

6876

67481

1.08

2.52

13.8

12.6

13.5

0.95

6752

66240

(3026389) Candida sp identified in Specimen by Organism specific culture

169

1326

1.28

2.50

1.4

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

568

1.43

2.49

2.1

2.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

315

2646

1.20

2.49

1.7

1.6

iu/ml

0.1

6.6

0.53

529

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

235

1918

1.23

2.48

1.4

1.3

u/ml

2.5

3.0

0.14

144

(3015235) Bicarbonate [Moles/volume] in Capillary blood

140

1074

1.31

2.47

2.8

2.7

mmol/l

24.7

24.3

0.63

119

945

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

151

1.86

2.46

1.0

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1894

17793

1.08

2.39

1.7

mg/l

1.0

0.9

0.78

1407

13278

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

271

2260

1.21

2.33

1.9

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

120

909

1.32

2.33

3.0

2.3

u/ml

868.6

1033.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1220

11262

1.10

2.32

2.6

2.5

ng/l

701.1

681.1

0.10

992

9164

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

518

1.43

2.32

1.6

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

195

1574

1.24

2.31

2.1

2.0

g/l

3.0

0.06

153

1238

(3022217) INR in Platelet poor plasma by Coagulation assay

607

5397

1.13

2.31

13.9

13.8

inr

1.2

1.1

0.39

108

888

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.22

2.30

7.1

3.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

320

2715

1.19

2.29

1.6

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

624

5562

1.13

2.28

1.3

au/ml

24.3

37.8

1.89

227

(21494814) CD8 cells/100 lymphocytes in Specimen

277

1.59

2.27

2.1

2.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

316

2681

1.19

2.26

5.1

6.3

mmol/l

24.2

24.4

0.44

297

2484

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

357

1.52

2.26

3.1

3.0

mg/l

9.4

7.8

0.55

272

(21494890) Protein electrophoresis panel - 24 hour Urine

349

1.52

2.26

1.8

1.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

194

1570

1.24

2.25

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

672

6023

1.13

2.25

2.3

au/ml

17.9

22.8

0.90

482

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

241

1996

1.21

2.24

2.4

2.1

mg/l

10.6

10.2

0.32

228

1882

(40761536) Microorganisms panel - Urine sediment

769

6948

1.12

2.24

3.9

3.4

—

(4281824)

128

985

1.30

2.24

1.0

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

332

2832

1.18

2.23

1.4

u/l

21.6

25.0

1.25

251

2344

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

113

855

1.33

2.23

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

369

3176

1.17

2.23

1.9

2.0

ug/l

6.4

5.5

0.16

321

2761

(3005988) Vibrio sp identified in Specimen by Organism specific culture

113

856

1.32

2.21

1.5

—

(4010399)

520

4592

1.14

2.21

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

361

4181

0.86

2.18

1.4

—

(3049717) Cytology report of Urine Cyto stain

140

1095

1.28

2.17

1.9

2.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.07

2.16

1.5

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

670

1.36

2.16

1.8

1.9

mg/l

17.4

26.0

1.31

186

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

159

1265

1.26

2.16

2.7

2.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

293

2482

1.19

2.15

2.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

380

3289

1.16

2.15

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

112

854

1.32

2.11

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

347

1.50

2.10

2.2

2.8

39.2

45.7

0.66

130

(3003458) Phosphate [Moles/volume] in Serum or Plasma

742

6717

1.11

2.10

6.7

4.8

mmol/l

1.0

0.36

698

6287

(3041806) Other cells [#/volume] in Blood by Manual count

522

0.61

2.09

1.2

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

200

1639

1.23

2.09

2.1

2.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

200

1639

1.23

2.09

2.1

2.0

g/l

3.7

0.20

150

1182

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

160

1281

1.25

2.07

1.7

1.8

g/l

38.2

38.8

0.65

139

1128

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

200

1641

1.22

2.07

2.1

2.0

g/l

7.3

0.25

156

1261

(3039000) Anion gap in Blood

131

1024

1.28

2.06

4.0

6.4

mmol/l

11.2

11.0

0.22

119

918

(3023520) Reticulocytes [#/volume] in Blood

402

3506

1.15

2.06

2.3

2.5

e9/l

70.9

72.1

0.23

306

2552

(3009445) Proteinase 3 Ab [Units/volume] in Serum

298

2539

1.18

2.06

1.6

u/ml

9.3

9.9

—

(3002179) Metamyelocytes/100 leukocytes in Blood

577

5155

1.13

2.06

4.0

3.8

0.8

0.6

0.28

123

910

(3018572) Chloride [Moles/volume] in Blood

131

1025

1.28

2.05

4.0

6.4

mmol/l

106.1

105.6

0.81

119

919

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

498

1.41

2.05

6.4

6.7

mg/l

12.0

11.3

0.45

470

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.18

2.04

1.2

2.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

162

1304

1.25

2.01

1.9

g/l

0.0

1.44

148

1198

(3028626) Oxygen [Partial pressure] in Capillary blood

121

940

1.29

2.01

3.1

2.3

kpa

8.8

8.7

0.14

108

877

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

175

1421

1.24

2.01

2.2

2.0

g/l

0.6

0.5

0.18

154

1254

(3004588) Protein electrophoresis panel - Serum or Plasma

331

2853

1.17

2.00

2.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4450

43217

1.06

2.00

2.9

3.0

ug/l

75.2

68.8

1.83

4188

41150

(3022948) Iron [Moles/volume] in Serum or Plasma

1093

10114

1.09

1.99

2.5

2.2

umol/l

14.7

14.3

0.80

993

9400

(3024522) Salmonella sp identified in Specimen by Organism specific culture

113

871

1.30

1.99

1.5

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

359

3116

1.16

1.98

1.3

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

320

1.50

1.97

1.1

u/ml

3.5

2.2

0.26

172

(3024928) Oxygen saturation in Venous blood

120

934

1.29

1.97

4.7

3.6

—

(40768446) Kidney Pathology biopsy report

209

1.63

1.97

1.7

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

144

1147

1.26

1.96

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

144

1147

1.26

1.96

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

621

5597

1.12

1.93

4.2

4.0

0.8

0.9

0.30

167

1220

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

882

8096

1.10

1.92

2.7

2.3

24.3

23.6

0.67

751

7002

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

184

1510

1.22

1.92

2.0

g/l

10.3

10.1

0.21

155

1297

(3027456) Digoxin [Moles/volume] in Serum or Plasma

406

1.43

1.88

2.8

3.2

nmol/l

0.8

0.34

297

(3010503) CD19 cells [#/volume] in Blood

415

1.42

1.87

2.9

2.6

e9/l

0.1

0.3

1.17

409

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

188

1552

1.22

1.87

1.4

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2347

22403

1.06

1.86

3.1

2.8

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.65

1.86

1.2

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

146

1174

1.25

1.85

1.8

1.9

g/l

0.0

0.50

132

1075

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6735

66274

1.06

1.85

3.9

3.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2425

23181

1.06

1.84

1.7

—

(3010421) pH of Blood

164

1338

1.23

1.83

4.3

2.8

7.4

0.28

130

1115

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

112

874

1.29

1.83

1.5

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7532

74408

1.08

1.81

3.8

mmol/l

2.9

1.15

7114

70414

(3047181) Lactate [Moles/volume] in Blood

194

1613

1.21

1.80

3.7

5.0

mmol/l

1.2

0.36

177

1415

(3023420) DNA double strand Ab [Units/volume] in Serum

132

1054

1.26

1.79

2.2

1.7

iu/ml

31.4

34.8

0.12

(3034860) Kappa light chains.free [Mass/volume] in Serum

136

1090

1.25

1.79

2.7

3.1

mg/l

35.4

40.1

0.35

113

881

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

191

1587

1.21

1.79

1.3

1.5

iu/ml

6.2

12.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

144

1162

1.24

1.79

1.8

1.9

g/l

0.0

0.00

131

1073

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

693

1.32

1.78

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

215

1.58

1.78

3.4

4.3

mg/l

5060.8

2474.3

0.21

154

(3020891) Body temperature

203

1699

1.20

1.77

3.7

4.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

113

890

1.27

1.73

1.5

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

689

1.31

1.71

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

566

5115

1.11

1.70

2.3

2.5

1.8

1.7

0.23

499

4567

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

462

5162

0.89

1.70

1.7

1.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

135

1089

1.24

1.70

2.7

3.1

mg/l

28.2

37.7

0.83

112

881

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

133

1.73

1.69

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

141

1144

1.24

1.68

2.5

2.0

g/l

131.2

129.9

0.26

101

847

(3021440) Promyelocytes/100 leukocytes in Blood

593

5380

1.11

1.67

4.3

4.1

0.1

0.2

1.54

158

1140

(3021788) Differential panel - Synovial fluid

120

960

1.25

1.63

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

284

2464

1.16

1.63

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

218

1853

1.18

1.62

1.3

1.4

ug/g

340.6

310.2

1.08

123

952

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

618

1.31

1.60

1.2

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

671

1.30

1.59

1.5

1.4

—

(3020650) Glucose [Presence] in Urine

238

1.51

1.59

1.1

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

515

1.34

1.58

3.9

2.9

—

(21494755) Public health laboratory ask at order entry panel

1099

11738

0.93

1.58

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

241

2071

1.17

1.58

1.5

1.7

titre

538.5

290.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

355

3139

1.14

1.57

2.2

2.1

u/l

39.1

39.6

0.23

326

2937

(3000492) Spirometry study

818

7567

1.09

1.55

1.3

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

578

1.32

1.54

2.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

286

2495

1.15

1.54

1.2

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

698

6413

1.10

1.54

2.5

2.3

u/l

33.5

36.2

0.49

583

5467

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

145

1.66

1.53

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

373

1.40

1.53

1.1

101.1

99.0

0.16

155

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

102

808

1.27

1.53

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

106

844

1.26

1.52

1.5

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

3.33

1.52

1.0

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

382

1.39

1.52

1.1

103.5

95.8

1.33

156

(3017569) Oxygen content in Arterial blood

161

1.62

1.52

2.9

2.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.86

1.50

5.6

5.1

ug/min

49.1

33.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

643

1.29

1.49

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

129

1054

1.23

1.48

1.5

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

284

2487

1.15

1.47

1.2

1.1

—

(3042733) HLA Ab [Presence] in Serum

171

1.58

1.45

4.5

4.8

—

(3025159) Blasts/100 leukocytes in Blood

567

5177

1.10

1.44

4.2

4.1

0.1

0.2

0.24

128

981

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7137

70512

1.06

1.44

3.2

mmol/l

1.2

1.18

6747

66885

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

128

1050

1.22

1.43

2.8

3.1

ratio

1.4

—

114

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

362

3229

1.13

1.42

2.3

2.5

ng/l

150.6

120.3

0.70

319

2891

(40760892) CBC W Ordered Manual Differential panel - Blood

2001

19164

1.06

1.41

4.2

3.9

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

207

1778

1.17

1.40

4.0

4.6

1.9

1.7

1.15

195

1657

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.18

1.39

1.0

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

532

5825

0.91

1.39

1.4

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

247

2828

0.87

1.39

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

536

4896

1.10

1.37

1.4

1.3

miu/ml

206.8

237.8

1.47

266

2519

(3007916) DNA double strand Ab [Titer] in Serum

104

1.73

1.36

1.0

1.4

—

151.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

222

1922

1.16

1.36

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1696

16183

1.06

1.36

2.3

2.1

umol/l

2193.2

2778.1

0.43

1516

14441

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

226

1961

1.16

1.35

3.5

3.0

0.6

0.7

1.56

214

1874

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

231

2008

1.15

1.35

3.6

3.1

1.6

1.3

1.71

231

1991

(3001964) Herpes simplex virus Ag [Presence] in Specimen

248

1.45

1.34

1.2

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

310

2751

1.13

1.34

3.7

2.8

kpa

5.2

5.1

1.92

284

2569

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.97

1.32

1.7

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7446

73706

1.06

1.31

3.6

3.5

mmol/l

4.8

4.9

0.73

7086

70217

(3007930) Methemoglobin/Hemoglobin.total in Blood

204

1762

1.16

1.30

4.0

4.7

0.9

1.37

192

1646

(3015171) Extractable nuclear Ab [Units/volume] in Serum

444

4029

1.11

1.30

1.3

u/ml

1.3

1.1

0.12

336

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

701

1.26

1.30

1.1

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

613

1.27

1.29

1.5

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

180

1543

1.17

1.27

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.72

1.27

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

190

1637

1.16

1.26

3.0

3.3

u/ml

152.4

340.5

0.84

161

1397

(3009466) Valproate [Moles/volume] in Serum or Plasma

114

939

1.22

1.26

5.2

5.4

umol/l

369.0

375.4

0.18

108

798

(40768797) Stomach Pathology biopsy report

1035

9751

1.07

1.26

1.2

—

(3006462) Nitrate [Presence] in Urine

345

1.36

1.25

2.5

2.6

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

388

1.34

1.25

1.2

1.1

122.3

117.4

0.38

342

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

311

1.38

1.25

1.7

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7407

73338

1.06

1.23

3.5

mmol/l

1.6

0.07

7033

69747

(3022621) pH of Urine by Test strip

520

4774

1.09

1.22

2.7

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.63

1.21

2.6

3.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.63

1.21

1.0

1.2

nmol/l

160.0

247.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

111

916

1.21

1.1

g/l

1.5

0.10

100

836

(3004716) Salmonella sp identified in Stool by Organism specific culture

598

5528

1.09

1.20

1.5

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

402

3650

1.11

1.19

2.3

g/l

66.8

67.2

0.55

363

3364

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.31

1.18

1.2

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

453

0.71

1.18

1.1

1.3

—

(4211845)

384

1.33

1.17

2.7

2.5

—

(3052851) Hemolysis interference index of Serum or Plasma

214

1873

1.15

1.17

2.7

2.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

165

1.52

1.17

1.7

1.6

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

256

1.41

1.17

1.5

1.7

au/ml

191.3

141.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

316

1.36

1.16

2.2

1.8

ug/l

62.1

22.3

0.65

310

(40767503) Oxygen content in Capillary blood by calculation

119

995

1.20

1.15

2.9

2.1

16.9

16.7

0.27

478

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

1.15

0.0

1.1

—

(3009343) pH of Capillary blood

303

2716

1.12

1.15

3.8

2.8

7.4

0.31

358

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.75

1.12

3.6

6.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1506

14405

1.05

1.12

4.1

3.9

mg/mmol

12.4

9.7

0.73

929

8865

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

103

1.65

1.12

1.1

—

(3007463) Buprenorphine [Presence] in Urine

1.90

1.12

14.5

5.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

242

1.41

1.11

1.5

1.4

—

(4015189)

1.71

1.11

2.6

2.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

234

1.41

1.10

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

292

2621

1.12

1.09

3.8

2.7

mmol/l

1.6

1.4

0.56

217

1838

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

201

1.44

1.09

1.8

2.0

—

(3051651) Icteric interference index of Serum or Plasma

355

1.33

1.08

3.2

—

(44813793)

730

1.22

1.06

1.1

—

(3012501) Base excess in Blood by calculation

133

1133

1.18

1.06

4.8

2.9

mmol/l

2.1

2.3

0.18

707

(3021901) Oxygen saturation in Capillary blood

758

1.22

1.05

3.3

2.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.12

1.05

1.6

1.3

nmol/l

320.3

562.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

257

2297

1.12

1.05

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

340

1.33

1.04

1.2

u/l

19.8

17.2

0.31

274

(3036180) Methadone [Presence] in Urine

2.27

1.03

3.4

2.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

616

1.24

1.02

1.9

2.1

11.8

13.1

0.33

335

(3030313) Adrenal Ab [Titer] in Serum

138

1.52

1.02

1.0

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

159

1380

1.15

1.01

1.3

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

190

1671

1.14

1.01

2.0

1.9

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

188

1.44

1.01

2.6

2.3

—

(3010937) Rubella virus Ab [Presence] in Serum

108

0.46

1.00

1.4

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.84

0.98

1.0

1.7

—

(3011412) CD3 cells [#/volume] in Blood

756

1.21

0.98

2.5

2.4

e9/l

1.4

1.3

0.32

448

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

223

1.39

0.98

3.9

3.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

223

1.39

0.98

3.2

2.9

ng/l

103.5

98.9

0.03

114

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

575

1.24

0.97

1.7

2.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

131

1125

1.17

0.97

2.9

3.8

u/ml

0.4

0.87

634

(40768441) Liver Pathology biopsy report

540

1.24

0.96

1.6

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

520

4834

1.08

0.96

3.5

3.1

mmol/l

1.2

1.15

451

4244

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

416

1.28

0.95

1.6

u/l

13.6

4.6

0.87

202

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

443

1.27

0.94

1.2

1.3

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

317

0.69

0.94

1.1

u/ml

65.0

52.8

0.32

310

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1370

13141

1.05

0.94

1.5

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

195

1729

1.13

0.93

1.4

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.22

0.93

1.2

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

143

0.56

0.93

1.0

—

(1761868) Lipid panel - Serum or Plasma

3050

31244

0.96

0.93

2.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

151

1317

1.15

0.92

1.5

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

690

1.20

0.90

1.5

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.63

0.90

2.8

2.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.07

0.89

1.0

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

243

2191

1.11

0.89

1.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

332

1.30

0.89

1.8

1.9

mg/l

8.4

9.5

0.75

271

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

181

1605

1.13

0.88

1.4

1.3

u/ml

143.0

109.1

0.69

384

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

164

1445

1.14

0.88

2.3

2.1

ug/l

359.6

474.2

0.26

151

1279

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

123

1421

0.86

0.88

1.1

115.2

119.7

0.84

112

1304

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.86

0.87

1.4

1.6

umol/24h

322.3

308.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.86

0.87

2.0

1.9

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.00

0.87

1.0

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

197

1759

1.12

0.86

1.3

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

114

1322

0.86

1.4

1.5

g/l

0.5

0.6

1.27

1003

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

556

5210

1.07

0.86

3.3

3.6

ug/l

5.9

26.3

1.73

412

3774

(3051387) C reactive protein [Mass/volume] in Capillary blood

121

1396

0.86

0.85

3.7

3.3

mg/l

28.9

22.2

0.68

844

(3011897) Casein IgE Ab [Units/volume] in Serum

204

0.64

0.85

1.0

1.1

—

1.8

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

344

1.28

0.84

1.2

1.1

u/l

78.6

75.6

0.14

285

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

213

1.36

0.84

1.0

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

660

1.20

0.84

1.6

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.76

0.83

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

212

1906

1.11

0.83

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

470

1.24

0.83

1.4

1.5

e6/l

27678.9

56040.5

0.42

327

(3043409) Potassium [Moles/volume] in Arterial blood

145

1274

1.14

0.83

2.9

3.8

mmol/l

3.8

0.06

138

1196

(3025315) Body weight

1.74

0.82

5.3

3.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

480

1.23

0.81

1.1

—

(3019174) dRVVT (LA screen)

105

1.52

0.81

1.1

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

172

1.40

0.80

1.2

1.1

nmol/l

0.4

0.08

114

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

539

5060

1.07

0.80

2.2

2.3

ml/min/173m2

75.8

76.4

0.12

205

1915

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

1088

0.85

0.80

1.4

1.5

mmol/l

10.4

10.9

0.26

138

(3040151) Glucose [Moles/volume] in Capillary blood

581

1.21

0.80

3.9

4.1

mmol/l

6.0

7.2

2.73

475

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.72

0.79

1.7

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

370

3427

1.08

0.79

1.5

—

(3011648) Oxygen content in Venous blood

374

1.26

0.79

2.3

2.4

10.3

10.9

0.48

374

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.82

0.79

1.2

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

564

0.80

0.79

17.2

16.9

nmol/l

1508.9

4477.2

0.79

541

(3003740) Influenza virus B Ag [Presence] in Specimen

211

1904

1.11

0.79

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

110

952

1.16

0.78

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.78

0.0

9.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

502

1.22

0.77

1.4

1.5

umol/l

24.5

26.4

0.21

481

(3039162) Centromere protein B Ab [Units/volume] in Serum

140

1235

1.14

0.77

1.4

1.3

u/ml

41.5

56.9

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

243

1.32

0.76

8.9

5.1

u/ml

48.2

2935.5

0.55

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

658

1.19

0.76

1.8

1.6

46.4

50.2

0.37

402

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

293

2693

1.09

0.76

2.4

2.1

iu/l

45.5

9.9

0.41

133

1137

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

200

1.35

0.76

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

200

1.35

0.76

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

200

1.35

0.76

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

107

1.50

0.76

1.0

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.70

0.75

1.5

1.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

191

1720

1.11

0.75

1.3

u/ml

20.1

20.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

284

3086

0.92

0.74

2.3

2.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

184

1656

1.11

0.74

1.3

1.2

u/ml

282.9

269.7

0.28

129

1110

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

151

1344

1.13

0.73

2.5

2.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

298

1.28

0.73

1.3

1.2

mmol/l

6.1

0.01

278

(3000475) Leukocytes [#/volume] in Synovial fluid

139

1231

1.13

0.73

1.8

1.7

e6/l

7363.7

8126.6

0.21

106

909

(3012516) Albumin [Mass/volume] in Urine

1427

13792

1.04

0.73

3.4

3.2

mg/l

382.7

489.7

0.39

885

8274

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

449

4209

1.07

0.72

3.9

3.3

ng/l

85.3

75.8

1.25

409

3718

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

617

1.18

0.71

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

907

8684

1.05

0.71

1.2

iu/ml

171.3

153.4

0.51

354

3480

(3006598) pH of Arterial cord blood

1.92

0.70

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

444

1.22

0.70

2.4

2.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

229

2091

1.10

0.70

1.3

titre

111.8

156.8

0.31

194

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

238

1.30

0.70

1.1

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

212

1.32

0.70

1.0

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

221

1.31

0.69

1.1

88.6

90.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

221

1.31

0.69

1.1

70.1

72.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

814

1.16

0.69

2.8

3.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

680

6469

1.06

0.69

1.2

1.3

u/ml

254.1

179.4

0.68

630

5984

(3000330) Specific gravity of Urine by Test strip

316

2931

1.08

0.68

3.1

2.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.59

0.68

1.0

1.1

umol/24h

1.5

1.6

0.10

(3016018) Differential panel - Cerebral spinal fluid

101

882

1.15

0.67

1.2

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.54

0.67

1.0

1.1

—

(3037121) Protein [Mass/volume] in Urine

215

1964

1.10

0.66

3.4

2.8

g/l

0.2

0.3

2.23

756

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

258

1.28

0.66

1.5

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

612

5812

1.06

0.66

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

159

1765

0.90

0.66

1.6

mmol/l

7.7

7.6

0.19

103

1094

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.53

0.66

1.0

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

539

0.82

0.66

13.4

12.2

nmol/l

870.3

842.9

0.17

519

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.59

0.65

1.1

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

1.59

0.65

1.0

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.57

0.65

1.0

1.1

u/ml

0.1

0.6

—

(4212803)

1.72

0.64

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

775

1.15

0.63

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

505

5330

0.94

0.62

1.4

1.5

—

(3015183) Erythrocyte sedimentation rate

609

1.17

0.61

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

738

7708

0.95

0.61

1.6

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

720

6889

1.05

0.60

3.4

pmol/l

4.6

4.5

0.71

644

6238

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1804

17580

1.03

0.60

1.6

mmol/l

1.4

1.3

0.53

1555

15330

(3024139) IgG subclass 3 [Mass/volume] in Serum

888

0.87

0.60

1.4

g/l

0.4

0.02

629

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.60

0.0

1.1

—

(3009754) Celery IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.60

0.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

505

5323

0.95

0.60

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

521

0.82

0.60

1.3

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

887

0.87

0.60

1.4

g/l

2.8

3.0

0.92

623

(3027135) IgG subclass 1 [Mass/volume] in Serum

887

0.87

0.60

1.4

g/l

6.9

6.6

0.24

627

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.59

0.0

1.2

—

(4306422)

135

1499

0.90

0.59

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

139

1253

1.11

0.58

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

123

1.38

0.57

1.5

1.4

—

(3037756) Immunofixation for Serum or Plasma

698

1.15

0.57

1.9

1.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

310

1.23

0.56

1.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

590

5631

1.05

0.56

1.5

1.6

mu/l

281.9

314.5

1.35

529

5000

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

240

2226

1.08

0.56

1.3

u/ml

48.8

38.3

0.52

234

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

108

963

1.12

0.55

1.6

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.45

0.55

1.3

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

461

0.82

0.55

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

280

2996

0.93

0.55

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

153

1679

0.91

0.55

1.1

au/ml

11.4

10.3

0.08

124

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

251

0.76

0.55

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

403

1.19

0.54

1.2

g/l

0.3

0.87

328

(3043238) Trisomy 21 risk [Likelihood] in Fetus

521

5468

0.95

0.54

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

228

0.75

0.54

2.9

1.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

142

1.34

0.54

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

151

1376

1.10

0.53

3.2

2.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.54

0.53

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

139

1528

0.91

0.52

1.3

1.2

u/ml

2.8

4.1

1.42

620

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

158

0.70

0.52

1.8

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

619

1.15

0.52

1.1

—

(3028433) Virus identified in Specimen by Culture

223

1.26

0.52

1.1

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.50

0.51

1.5

1.3

—

(3009677) Dengue virus Ab [Presence] in Serum

1.50

0.51

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

126

1.35

0.51

1.1

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

256

2391

1.07

0.51

2.1

2.3

162.9

166.7

0.35

244

2253

(3008295) Osmolality of Serum or Plasma

564

1.15

0.51

1.6

1.7

mosm/kgh2o

279.6

281.9

0.36

453

(3013247) Albumin in CSF/Albumin in Serum or Plasma

259

0.77

0.51

1.0

1.1

mg/g

5.1

0.02

242

(3032057) Clostridioides difficile [Presence] in Stool

109

1.38

0.50

1.8

2.0

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

233

1.25

0.50

1.1

106.3

107.8

0.13

218

(3020393) Adenovirus Ag [Presence] in Stool

1.38

0.50

1.1

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

171

1573

1.09

0.50

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

247

0.77

0.50

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

763

1.13

0.50

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

390

0.82

0.50

1.3

1.5

nmol/l

123.1

130.5

0.50

390

(3016650) Hepatitis A virus Ab [Presence] in Serum

144

1316

1.10

0.49

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

679

1.14

0.49

4.5

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

764

1.13

0.49

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

1029

0.89

0.49

3.9

4.4

u/ml

101.9

105.7

0.02

330

(3035880) pH of Pleural fluid

136

1.32

0.49

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

774

1.13

0.49

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

774

1.13

0.49

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.56

0.48

1.3

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

145

1.31

0.48

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

795

7674

1.04

0.48

2.0

nmol/l

383.3

376.2

0.47

732

7083

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

155

0.71

0.48

2.8

3.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

155

0.71

0.48

2.8

3.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.52

0.48

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

775

1.12

0.48

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

1.40

0.48

1.0

u/ml

0.1

0.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

766

1.12

0.47

1.2

—

(3045716) Anion gap in Serum or Plasma

199

1.26

0.47

6.7

2.2

mmol/l

10.6

9.1

0.74

153

(40761539) Cells [Type] in Urine sediment by Light microscopy

143

0.70

0.47

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

720

0.87

0.47

1.1

1.2

u/ml

0.1

1.0

1.88

278

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

592

0.86

0.47

5.9

6.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

410

1.17

0.47

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

102

1.37

0.47

1.2

1.6

ng/l

108.3

58.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1234

12675

0.97

0.47

2.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.41

0.46

1.7

1.9

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

643

0.87

0.45

1.1

u/l

1.0

0.86

257

(3047189) Immunofixation for 24 hour Urine

147

1.29

0.45

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

349

3312

1.06

0.45

1.2

u/l

10.7

12.1

1.37

291

2769

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

406

0.84

0.44

1.1

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

316

2992

1.06

0.44

2.4

e6/l

0.2

0.09

302

2856

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.37

0.44

1.0

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

293

1.20

0.43

1.1

—

(4094501)

158

1461

1.08

0.43

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.37

0.43

1.2

—

(1616796) Gas panel - Central venous blood

121

1106

1.10

0.43

4.6

2.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

241

0.79

0.43

1.1

1.2

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.61

0.43

1.2

1.1

u/l

128.2

286.9

—

(3005011) Chlamydia sp Ab [Titer] in Serum

151

0.73

0.42

1.4

1.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.56

0.42

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.40

0.42

1.0

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

708

1.12

0.41

1.2

u/l

54.2

56.1

0.16

473

(3045683) HLA typing for celiac disease panel - Blood or Tissue

727

1.12

0.41

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.52

0.41

2.0

1.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

323

1.18

0.41

1.3

1.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.41

0.0

2.3

—

(4062490)

889

0.90

0.40

1.4

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.40

0.0

1.1

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

767

1.11

0.40

1.0

1.1

u/ml

0.4

1.3

0.91

200

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

158

1468

1.08

0.40

1.0

u/ml

0.2

0.3

0.09

297

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

709

6862

1.04

0.40

1.5

—

(3022689) Creatine [Moles/volume] in Urine

159

1.26

0.40

1.1

1.4

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.40

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.40

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.40

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.40

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.40

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.40

0.0

1.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

739

1.11

0.39

1.8

2.0

u/ml

3.5

1588.7

0.59

638

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

103

0.68

0.39

1.0

1.1

—

3.2

—

(40768806) Pleura Pathology biopsy report

281

0.82

0.39

1.7

1.4

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.39

0.0

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

196

1.23

0.39

3.5

3.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

226

0.80

0.39

2.8

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

226

0.80

0.39

2.8

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

113

1037

1.09

0.39

1.3

—

(3036603) Volume of Urine

400

1.15

0.38

1.5

1713.6

2151.9

—

(3008898) HLA-B27 [Presence]

458

4399

1.04

0.38

1.1

—

(44806420)

1.34

0.38

2.8

2.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

136

0.73

0.37

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

905

1.09

0.37

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

536

0.88

0.37

1.0

1.1

miu/ml

1576.6

1490.8

0.19

536

(40757373) Influenza virus identified in Isolate

114

0.70

0.37

1.0

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

768

7907

0.97

0.37

1.5

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.29

0.36

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

669

6483

1.03

0.36

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1007

0.91

0.36

2.9

2.6

ug/min

53.4

78.5

0.55

638

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

665

6444

1.03

0.36

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

343

0.84

0.36

1.6

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

431

1.14

0.36

1.1

—

(3019977) pH of Arterial blood

235

1.19

0.36

2.3

3.0

7.4

0.37

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

300

1.17

0.36

1.4

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

1.33

0.35

1.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

263

1.18

0.35

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

190

0.79

0.35

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

190

0.79

0.35

1.1

—

(3042517) Benzodiazepines panel - Urine

162

1.24

0.35

2.0

2.4

—

(40765096) Chromosome analysis panel by Banding

126

1.27

0.35

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

667

6470

1.03

0.35

1.4

—

(40758358) Immune stain study

1.40

0.35

1.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

565

1.12

0.35

2.8

2.5

e9/l

0.2

0.31

469

(3044242) Glucose [Moles/volume] in Arterial blood

199

1.21

0.35

2.7

2.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

182

1712

1.06

0.34

4.1

2.8

mmol/l

24.8

24.7

0.24

174

1592

(3035933) Granulocytes/100 leukocytes in Blood

292

1.17

0.34

1.5

1.9

—

(3029612) Listeria sp Ab [Titer] in Serum

1.36

0.34

1.7

1.4

—

(3045142) Bone marrow Pathology biopsy report

471

1.13

0.34

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

447

0.87

0.34

1.9

2.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

137

1468

0.93

0.34

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.33

0.33

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

668

6488

1.03

0.33

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1367

13408

1.02

0.33

1.6

pmol/l

28041858.2

29601803.8

0.04

1159

11665

(3003338) MCHC [Mass/volume]

6932

69624

0.98

0.33

14.5

13.2

g/l

332.1

331.7

3.51

6884

69149

(3042631) Mycobacterium sp identified in Specimen

520

1.12

0.33

2.3

2.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

521

5040

1.04

0.33

1.1

titre

70.4

226.6

3.38

126

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

170

1601

1.06

0.32

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.35

0.32

1.1

2.1

u/field

0.5

0.9

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

132

0.76

0.32

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

674

1.10

0.32

1.1

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

187

0.80

0.32

1.1

—

(3014271) Vancomycin [Susceptibility]

137

1.24

0.32

2.1

2.8

—

(3023419) Bacteria identified in Sputum by Culture

550

1.11

0.31

2.7

2.6

—

(3034426) Prothrombin time (PT)

327

0.86

0.31

1.2

—

(3024263) Appearance of Synovial fluid

273

0.84

0.31

1.7

2.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

147

1565

0.94

0.31

1.3

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

217

2062

1.05

0.31

1.2

1.3

mg/l

559.7

455.9

0.63

209

1973

(3044941) Cell count panel - Synovial fluid

810

1.09

0.31

1.4

—

(3012441) Differential panel - Pleural fluid

258

1.16

0.30

1.4

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

305

1.15

0.30

1.4

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

543

1.11

0.30

1.6

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

174

0.80

0.29

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

141

0.78

0.29

1.0

u/ml

0.6

0.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

255

2665

0.96

0.29

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

858

0.92

0.29

1.4

1.3

umol/l

6.0

5.5

0.62

791

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

107

0.75

0.29

1.1

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

148

1569

0.94

0.28

1.3

1.2

u/ml

3.3

3.2

0.02

519

(3010726) Horse dander IgE Ab [Units/volume] in Serum

217

2070

1.05

0.28

1.1

u/ml

1.5

1.7

0.06

507

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

355

1.13

0.28

1.7

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

365

1.12

0.27

1.1

1.2

109.1

109.7

0.05

332

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

233

1.16

0.27

1.5

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

233

1.16

0.27

1.5

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

205

1.17

0.27

1.9

1.7

ug/l

8.0

8.4

0.27

205

(3001556) Androgen free Index in Serum or Plasma

150

0.80

0.27

1.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

624

1.09

0.27

1.8

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

576

1.09

0.27

2.7

2.5

e6/l

588.3

507.8

0.96

470

(3044290) Cell count panel - Cerebral spinal fluid

181

1722

1.05

0.26

1.2

1.3

—

(3024471) HLA-A [Type]

187

1.18

0.26

1.0

—

(3020491) Glucose [Moles/volume] in Blood

615

1.09

0.26

1.4

1.6

mmol/l

5.9

0.04

490

(3001893) Eosinophils/100 leukocytes in Pleural fluid

1.19

0.26

1.3

1.5

1.9

4.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

405

0.89

0.26

1.0

—

(3045788) Cell count panel - Pleural fluid

253

1.15

0.26

1.3

1.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

697

0.92

0.26

1.3

titre

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

141

1.21

0.26

1.3

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

272

1.14

0.26

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

355

3432

1.04

0.26

1.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

616

1.09

0.25

2.8

3.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

299

0.87

0.25

1.2

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

568

1.09

0.25

1.2

titre

217.5

191.7

0.09

112

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

549

1.09

0.25

1.9

1.6

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

138

0.80

0.25

1.0

1.2

mg/l

0.8

86.3

—

105

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

684

1.08

0.25

1.2

1.1

ratio

1.1

0.11

258

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

923

0.93

0.25

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

627

1.09

0.25

1.6

1.7

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

120

1131

1.06

0.25

1.4

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

245

1.14

0.24

1.1

—

(3002619) Bacteria identified in Specimen by Culture

142

1.20

0.24

1.6

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

148

0.81

0.24

3.4

7.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.26

0.24

1.2

2.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.73

0.24

1.3

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

350

1.11

0.24

1.5

1.6

u/field

2.7

2.2

0.16

255

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

144

1516

0.95

0.24

1.2

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

861

1.07

0.24

1.9

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

398

1.11

0.23

1.3

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

827

0.93

0.23

1.4

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

222

0.86

0.23

1.0

ng/l

262.1

331.9

1.13

164

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

190

0.84

0.23

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

930

1.07

0.23

1.5

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

422

0.90

0.23

1.5

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

106

1.23

0.23

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

991

0.94

0.23

1.0

1.1

—

75.9

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

270

2605

1.04

0.23

2.0

2.2

umol/l

4.6

5.0

0.45

194

1886

(3022313) Gas panel - Capillary blood

199

1909

1.04

0.22

4.0

2.8

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

266

1.13

0.22

1.1

iu/ml

—

3.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.76

0.22

1.6

—

(3033799) Differential panel - Peritoneal fluid

125

1.20

0.22

2.1

2.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

127

1205

1.05

0.22

1.2

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

477

1.09

0.22

2.8

2.7

mg/l

146.4

54.1

0.39

334

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

381

1.10

0.22

1.4

1.7

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.22

0.22

1.0

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

135

0.81

0.21

1.4

1.3

—

(40768795) Lymph node Pathology biopsy report

661

1.07

0.21

1.1

1.2

—

(40768793) Breast Pathology biopsy report

247

2559

0.96

0.21

1.2

1.3

—

(40758292) HTLV I+II Ab panel - Serum

107

1.22

0.21

1.3

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

1.19

0.21

1.0

1.2

ug/g

286.8

149.3

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

507

1.09

0.21

1.7

1.6

40.7

40.2

0.03

300

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1166

11834

0.98

0.21

1.5

—

(3017704) Immunofixation for Urine

182

1.15

0.21

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

315

1.11

0.21

1.3

1.4

e6/l

11564.1

2810.6

0.46

226

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

102

0.78

0.21

1.0

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

123

1170

1.05

0.20

3.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

136

1.18

0.20

1.3

1.6

ug/l

0.6

0.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.22

0.20

1.3

1.1

u/l

20.3

12.8

—

(4034850)

227

2350

0.97

0.20

8.0

7.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

791

1.06

0.19

1.1

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

178

1711

1.04

0.19

1.1

u/ml

4.4

3.9

0.16

705

(3037692) Legionella sp identified in Specimen by Organism specific culture

174

1.15

0.19

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

217

2095

1.04

0.19

1.3

titre

1138.6

934.0

0.23

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

260

0.88

0.19

1.7

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

870

0.94

0.19

2.4

2.5

mmol/l

1.4

0.03

848

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

116

1218

0.95

0.19

1.1

iu/ml

137.8

8538.1

0.63

315

(3014133) Dog dander IgE Ab [Units/volume] in Serum

189

1821

1.04

0.19

1.1

u/ml

3.6

4.3

0.19

684

(3013005) Retinol [Moles/volume] in Serum or Plasma

414

1.09

0.19

2.0

1.6

umol/l

2.0

1.9

0.31

385

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

681

6934

0.98

0.18

1.3

—

(3004775) Volume in Urine collected for unspecified duration

311

0.90

0.18

2.6

2.4

591.0

610.8

0.13

247

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

185

0.86

0.18

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

223

1.12

0.18

2.0

2.2

—

(40762365) Oxygen content in Arterial blood by calculation

1.19

0.18

1.9

ml/dl

14.5

14.9

—

(4024509)

590

1.07

0.17

1.3

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

1.15

0.17

1.9

4.8

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

322

3138

1.03

0.17

1.3

ug/l

3.8

3.1

0.29

294

2884

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

268

0.90

0.17

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

226

0.88

0.17

1.1

1.0

ng/l

32.5

46.1

1.47

163

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

120

1253

0.96

0.17

1.8

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

388

1.08

0.16

1.2

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

376

3676

1.02

0.16

2.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

225

0.89

0.16

1.0

ng/l

955.7

761.5

0.82

165

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

204

0.88

0.16

1.1

1.0

u/ml

5.6

0.6

0.42

137

(4133840)

183

0.87

0.16

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.11

0.16

10.4

8.8

—

(1002224) Polysomnography panel

380

3718

1.02

0.16

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

428

1.08

0.16

1.7

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

287

0.91

0.15

2.3

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

187

1811

1.03

0.15

1.8

—

(21494434) Karyotype in Bone marrow

328

0.91

0.15

1.1

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

526

1.07

0.15

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.14

0.15

1.2

1.1

—

(3017509) Phencyclidine [Presence] in Urine

140

1.14

0.15

1.1

1.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.08

0.14

1.6

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

159

1643

0.97

0.14

3.3

3.7

u/ml

34.7

26.7

0.45

149

1589

(4146454)

409

0.93

0.14

2.9

3.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

479

1.07

0.14

1.5

1.4

u/l

4.4

5.2

1.84

417

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

285

0.91

0.14

2.3

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

285

0.91

0.14

2.3

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

285

0.91

0.14

2.3

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

164

1692

0.97

0.14

1.5

mmol/l

7.1

6.7

0.86

122

1220

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

470

0.94

0.14

1.0

1.1

90.0

91.8

0.14

385

(3034988) Calcium [Moles/volume] in Capillary blood

0.83

0.13

2.6

2.0

mmol/l

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

189

1.11

0.13

1.4

1.5

—

(3048879) Bone marrow aspiration report

0.81

0.13

2.5

2.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

582

0.94

0.13

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

989

0.96

0.13

1.1

—

25.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

256

2502

1.02

0.13

1.9

2.0

93.1

95.2

0.72

240

2292

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

110

0.82

0.13

1.0

—

(44806071)

142

1.13

0.12

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

794

0.96

0.12

1.2

1.1

—

(3036489) Thrombin time

294

2881

1.02

0.12

1.8

1.9

20.9

20.7

0.34

244

2411

(3038515) Glucose [Moles/volume] in Venous blood

804

0.96

0.12

2.5

mmol/l

6.9

7.2

0.57

784

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

512

1.06

0.12

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

532

1.05

0.11

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.16

0.11

1.2

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

143

1.12

0.11

2.5

2.3

e6/l

403.4

818.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

167

1714

0.97

0.11

1.0

1.1

u/ml

2.5

2.7

0.10

943

(3014599) Egg white IgE Ab [Units/volume] in Serum

759

1.04

0.11

1.0

u/ml

1.2

0.7

0.20

167

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

730

1.04

0.11

1.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

130

1337

0.97

0.10

1.4

nmol/l

30.7

31.6

0.16

123

1229

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

107

1037

1.03

0.10

1.1

1.2

nmol/l

0.5

1.6

0.53

101

1005

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

348

3535

0.98

0.10

1.6

1.7

—

(3024932) HLA-DR beta [Type]

183

1.09

0.10

1.2

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

486

1.05

0.10

1.0

1.1

u/ml

13.2

9.8

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.14

0.10

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

114

0.88

0.09

2.6

2.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.06

0.09

1.0

—

(4027681)

716

0.96

0.09

1.3

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

882

1.03

0.09

3.3

3.4

u/ml

212.1

523.9

0.50

808

(3017446) Testosterone [Moles/volume] in Serum or Plasma

131

1343

0.98

0.09

1.4

1.3

nmol/l

1.5

1.3

0.36

110

1109

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

331

1.06

0.08

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

253

1.07

0.08

1.4

1.2

nmol/l

6.8

5.6

0.83

239

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

312

1.06

0.08

1.1

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.81

0.08

1.2

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

491

0.96

0.08

1.0

1.1

nmol/l

0.1

3.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

154

0.91

0.08

1.1

1.0

—

(3004451) EKG impression Narrative

156

1.09

0.08

1.2

1.3

—

(3044927) Protein electrophoresis panel - Urine

348

0.95

0.08

1.2

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

368

0.95

0.07

1.1

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

439

0.96

0.07

1.9

1.6

nmol/l

1.4

15.2

0.60

362

(3038177) Helicobacter pylori Ab [Presence] in Serum

171

1742

0.98

0.07

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

125

1278

0.98

0.07

1.7

1.5

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.05

0.07

1.0

—

(40768443) Skin Pathology biopsy report

309

3051

1.01

0.07

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

620

1.03

0.07

1.2

u/l

14.9

26.3

1.46

540

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.87

0.06

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

295

0.95

0.06

2.4

2.2

ug/l

1.6

1.2

0.37

282

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

890

1.02

0.05

1.1

1.2

mg/l

32.4

36.0

0.62

751

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

247

1.05

0.05

1.0

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

297

1.04

0.05

1.2

1.3

—

633.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

418

4148

1.01

0.05

1.8

1.6

mg/l

3.0

3.4

0.76

278

2860

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

116

1141

1.02

0.04

3.8

2.7

nmol/l

1.0

0.8

0.90

101

962

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

605

0.98

0.04

1.6

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

1.10

0.04

1.4

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

246

2437

1.01

0.04

1.1

u/ml

0.8

1.2

0.45

903

(3036048) Francisella tularensis Ab [Titer] in Serum

160

0.94

0.04

1.1

—

213.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

287

2847

1.01

0.04

1.5

nmol/l

0.5

0.27

232

2292

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

557

1.02

0.03

1.1

1.2

u/ml

7.0

15.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

129

0.93

0.03

2.7

2.1

e6/l

1105.8

21904.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

139

0.94

0.03

1.2

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

985

9819

1.00

0.03

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

185

1834

1.01

0.03

1.2

mmol/l

3.5

3.6

0.28

176

1717

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

261

1.03

0.02

1.2

36.7

15.2

—

(44790048)

651

0.98

0.02

1.4

—

(44790047)

651

0.98

0.02

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

300

3017

0.99

0.02

1.1

u/ml

3.6

4.6

0.41

477

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

149

1477

1.01

0.02

2.4

1.9

ug/l

4.1

1.9

0.78

128

1298

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

381

1.02

0.02

3.5

4.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

640

1.02

0.02

1.1

1.2

—

(44806118)

650

0.98

0.02

1.4

—

(44790049)

650

0.98

0.02

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

184

1827

1.01

0.02

1.2

1.3

e6/l

82.2

23.8

0.41

141

1422

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

441

1.02

0.02

2.1

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

441

1.02

0.02

2.1

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

441

1.02

0.02

2.1

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

184

1828

1.01

0.02

1.2

1.4

e6/l

655.8

3443.4

0.76

146

1499

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

143

1.05

0.01

1.1

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

220

2190

1.00

0.01

1.0

1.1

u/ml

5.5

4.8

0.24

103

1121

(3008401) Mugwort IgE Ab [Units/volume] in Serum

207

2061

1.00

0.01

1.0

1.1

u/ml

1.4

0.9

0.40

831

(3035637) Corticotropin [Mass/volume] in Plasma

943

1.01

0.01

1.8

1.6

—

(3011985) Renin [Units/volume] in Plasma

943

1.01

0.01

1.9

1.7

mu/l

30.8

50.5

2.41

860

(3036670) Protein [Mass/volume] in Synovial fluid

114

1.05

0.00

1.4

1.2

g/l

35.5

38.6

—

(3044007) Cell count panel - Peritoneal fluid

116

0.95

0.00

3.7

2.1

—

(4268621)

106

1067

0.99

0.00

2.1

2.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

704

1.01

0.00

1.0

1.1

iu/ml

8.6

7.9

0.12

222

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

844

1.01

0.00

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

167

1.02

0.00

3.9

4.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

277

1.01

0.00

1.3

1.4

e6/l

22371.2

63759.4

0.75

156

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

343

0.99

0.00

1.3

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

403

0.99

0.00

1.3

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

224

0.98

0.00

3.0

2.7

—

(3000012) Reticulocyte production index

256

1.02

0.00

1.1

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

867

1.00

0.00

1.5

pmol/l

343.6

379.8

0.25

688

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

366

1.01

0.00

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

464

0.99

0.00

1.7

1.9

u/field

5.0

1.8

0.89

225

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

696

1.01

0.00

1.4

1.6

—

(3023410) Appearance of Cerebral spinal fluid

866

1.00

0.00

1.1

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

866

1.00

0.00

1.0

1.1

mg/l

197.0

206.4

0.41

760

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

936

1.00

0.00

1.1

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

168

1684

1.00

0.00

1.4

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

595

1.01

0.00

1.1

mg/l

309.8

298.9

0.59

535

(3034092) Cytoplasmic Ig cells/100 cells in Blood

122

0.98

0.00

9.7

5.8

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

232

0.99

0.00

1.2

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

278

1.01

0.00

1.6

1.5

2.4

4.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

382

0.99

0.00

1.3

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

442

1.00

0.00

1.3

1.2

57.9

69.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

381

1.00

0.00

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

279

1.00

0.00

1.5

2.2

e6/l

272.9

174.7

0.34

152

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

661

1.00

0.00

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

109

1.01

0.00

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

181

0.99

0.00

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

181

0.99

0.00

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

181

0.99

0.00

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

181

0.99

0.00

1.2

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.00

0.00

2.6

1.9

mmol/l

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

4.6

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

330

1.00

0.00

1.2

1.4

u/ml

12.7

18.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.99

0.00

1.0

1.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.02

0.00

1.4

3.3

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.90

0.00

1.0

1.1

u/ml

0.4

0.2

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

160.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.90

0.00

12.3

9.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1398.9

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.90

0.00

3.0

6.9

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.4

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.96

0.00

1.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.91

0.00

1.4

1.6

—

(3022475) Manganese [Moles/volume] in Blood

0.87

0.00

1.0

1.2

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.0

—

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.96

0.00

1.2

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.98

0.00

1.6

3.2

—

(3027020) Pear IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

0.91

0.00

1.1

—

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.97

0.00

1.3

1.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.01

0.00

1.0

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

310.5

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.2

—

5.6

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

180

1.00

0.00

1.7

1.3

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_FEMALE_GENITAL_HSIL and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_FEMALE_GENITAL_HSIL	1.321 [1.18, 1.48]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.16

During the follow-up period (1.1.1998 — 31.12.2019), 1896 out of 47005 females with N14_FEMALE_GENITAL_HSIL died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_FEMALE_GENITAL_HSIL.

N-year risk	Females	Males
1	0.146%	No data
5	0.826%	No data
10	1.991%	No data
15	3.594%	No data
20	6.228%	No data

Relationships between endpoints

↥

Index endpoint: N14_FEMALE_GENITAL_HSIL – HSIL lesion of the cervix uteri, vagina or vulva

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

HSIL lesion of the cervix uteri, vagina or vulva

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints